Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Su

Showing results (971-980 of 1,172) with videos related to

Pageof 118
Sort By:
Carcinogenesis|September 15, 2023
Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years oldJia-Yi Su, Yun Wang, Shang-Shang Wu, et al.
Optics Express|January 13, 2018
Experimental observation of quantum state-independent contextuality under no-signaling conditionsYa Xiao, Zhen-Peng Xu, Qiang Li, et al.
ACS Applied Materials & Interfaces|October 22, 2025
Gd<sub>2</sub>O<sub>3</sub> Doped with Yb<sup>3+</sup>/Er<sup>3+</sup> for Boosted Downshifting Pathway in NIR-IIb Region and Exploring the Dynamics of MRI/NIR-II Imaging in the NanophosphorAishwarya Satpathy, Tzu-Hsuan Liu, Ting-Yi Su, et al.
Leukemia Research|March 30, 2013
Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: a multicenter, randomized control trial in southwest ChinaXi Zhang, Yunlong Li, Yanqi Zhang, et al.
Nature Communications|January 7, 2023
One-dimensional semimetal contacts to two-dimensional semiconductorsXuanzhang Li, Yang Wei, Zhijie Wang, et al.
Plos Pathogens|June 24, 2021
Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2Min Zhao, Pei-Yi Su, Danielle A Castro, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer modelsXia Peng, Pengcong Hou, Yi Chen, et al.
Acta Pharmacologica Sinica|April 18, 2017
Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitorsZhong-Min Yang, Xue-Mei Liao, Yi Chen, et al.
Leukemia Research|March 9, 2017
Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantationLei Gao, Jia Liu, Yanqi Zhang, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Discovery of JND3229 as a New EGFR<sup>C797S</sup> Mutant Inhibitor with In Vivo Monodrug EfficacyXiaoyun Lu, Tao Zhang, Su-Jie Zhu, et al.
Pageof 118

Showing results (971-980 of 1,172) with videos related to

Sort By:
Pageof 118
Carcinogenesis|September 15, 2023
Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years oldJia-Yi Su, Yun Wang, Shang-Shang Wu, et al.
Optics Express|January 13, 2018
Experimental observation of quantum state-independent contextuality under no-signaling conditionsYa Xiao, Zhen-Peng Xu, Qiang Li, et al.
ACS Applied Materials & Interfaces|October 22, 2025
Gd<sub>2</sub>O<sub>3</sub> Doped with Yb<sup>3+</sup>/Er<sup>3+</sup> for Boosted Downshifting Pathway in NIR-IIb Region and Exploring the Dynamics of MRI/NIR-II Imaging in the NanophosphorAishwarya Satpathy, Tzu-Hsuan Liu, Ting-Yi Su, et al.
Leukemia Research|March 30, 2013
Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: a multicenter, randomized control trial in southwest ChinaXi Zhang, Yunlong Li, Yanqi Zhang, et al.
Nature Communications|January 7, 2023
One-dimensional semimetal contacts to two-dimensional semiconductorsXuanzhang Li, Yang Wei, Zhijie Wang, et al.
Plos Pathogens|June 24, 2021
Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2Min Zhao, Pei-Yi Su, Danielle A Castro, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer modelsXia Peng, Pengcong Hou, Yi Chen, et al.
Acta Pharmacologica Sinica|April 18, 2017
Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitorsZhong-Min Yang, Xue-Mei Liao, Yi Chen, et al.
Leukemia Research|March 9, 2017
Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantationLei Gao, Jia Liu, Yanqi Zhang, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Discovery of JND3229 as a New EGFR<sup>C797S</sup> Mutant Inhibitor with In Vivo Monodrug EfficacyXiaoyun Lu, Tao Zhang, Su-Jie Zhu, et al.
Pageof 118